Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2022

View Archived Issues

LONP1 targeting sensitizes therapy-resistant tumor cells to sorafenib

VesiVax Af3/9 vaccine protects against invasive pulmonary aspergillosis

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

Beijing Innocare Medical Technology patents JAK inhibitors

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

Shanghai Visonpharma discloses new GTPase KRAS inhibitors

Galapagos NV presents new DDR inhibitors

Chinese researchers synthesize new GTPase KRAS inhibitors

Royal College of Surgeons in Ireland discloses HDAC6 inhibitors

Co-targeting MAPK and YAP-TEAD signaling as therapeutic strategy in melanoma

Targeting IL-33 release may be an approach for treating HCC

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

Novel genetic loci found for venous thromboembolism

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...